Use of public datasets in the examination of multimorbidity: Opportunities and challenges.


Journal

Mechanisms of ageing and development
ISSN: 1872-6216
Titre abrégé: Mech Ageing Dev
Pays: Ireland
ID NLM: 0347227

Informations de publication

Date de publication:
09 2020
Historique:
received: 05 06 2020
accepted: 01 07 2020
pubmed: 6 7 2020
medline: 14 9 2021
entrez: 6 7 2020
Statut: ppublish

Résumé

The interrogation of established, large-scale datasets presents great opportunities in health data science for the linkage and mining of potentially disparate resources to create new knowledge in a fast and cost-efficient manner. The number of datasets that can be queried in the field of multimorbidity is vast, ranging from national administrative and audit datasets, large clinical, technical and biological cohorts, through to more bespoke data collections made available by individual organisations and laboratories. However, with these opportunities also come technical and regulatory challenges that require an informed approach. In this review, we outline the potential benefits of using previously collected data as a vehicle for research activity. We illustrate the added value of combining potentially disparate datasets to find answers to novel questions in the field. We focus on the legal, governance and logistical considerations required to hold and analyse data acquired from disparate sources and outline some of the solutions to these challenges. We discuss the infrastructure resources required and the essential considerations in data curation and informatics management, and briefly discuss some of the analysis approaches currently used.

Identifiants

pubmed: 32622995
pii: S0047-6374(20)30106-8
doi: 10.1016/j.mad.2020.111310
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

111310

Subventions

Organisme : Medical Research Council
ID : MR/P020941/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Christopher Boulton (C)

National Joint Registry, Dawson House, 5 Jewry Street, London, EC3N 2EX, United Kingdom.

J Mark Wilkinson (JM)

National Joint Registry, Dawson House, 5 Jewry Street, London, EC3N 2EX, United Kingdom; University of Sheffield, Metabolic Bone Unit, Sorby Wing, Northern General Hospital, Sheffield, S5 7AU, United Kingdom; Healthy Lifespan Institute, University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, United Kingdom. Electronic address: j.m.wilkinson@sheffield.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH